Compare AURA & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURA | PGC |
|---|---|---|
| Founded | 2007 | 1921 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 713.4M | 836.7M |
| IPO Year | 2021 | 1997 |
| Metric | AURA | PGC |
|---|---|---|
| Price | $7.63 | $46.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $20.00 | ★ $40.50 |
| AVG Volume (30 Days) | ★ 411.3K | 199.0K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.48% |
| EPS Growth | N/A | ★ 13.51 |
| EPS | N/A | ★ 1.65 |
| Revenue | N/A | ★ $282,995,000.00 |
| Revenue This Year | N/A | $32.39 |
| Revenue Next Year | N/A | $12.64 |
| P/E Ratio | ★ N/A | $28.02 |
| Revenue Growth | N/A | ★ 24.05 |
| 52 Week Low | $4.73 | $24.71 |
| 52 Week High | $9.54 | $49.14 |
| Indicator | AURA | PGC |
|---|---|---|
| Relative Strength Index (RSI) | 56.65 | 53.72 |
| Support Level | $6.65 | $42.60 |
| Resistance Level | $7.70 | $47.47 |
| Average True Range (ATR) | 0.39 | 1.26 |
| MACD | 0.06 | -0.06 |
| Stochastic Oscillator | 57.86 | 56.89 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.